|
1-hydroxy-3-methylcholanthrene
|
C022236 |
|
|
2-(4-hydroxyphenyl)-N,N-di-n-propylcyclopropylamine
|
C061811 |
|
|
2-hydroxy-3-methylcholanthrene
|
C022237 |
|
|
isoperisone
|
C061812 |
|
|
22(R)-hydroxydesmosterol
|
C022238 |
|
|
glycine-proline-proline polymer
|
C061813 |
|
|
protein kinase inhibitor peptide (1-31)
|
C061814 |
|
|
dimethyl pyrocarbonate
|
C061815 |
|
|
phosphatidylinositol-3-phosphatase
|
C061816 |
|
|
phosphonoglycosphingolipid FGL-IIb
|
C061817 |
|
|
1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine
|
C061818 |
|
|
Secosteroids
|
D012632 |
[Steroids in which fission of one or more ring structures and concomitant addition of a hydrogen atom at each terminal group has occurred.
] |
|
teichoicase
|
C036870 |
|
|
Secretin
|
D012633 |
[A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p597)
] |
|
methanesulfonamide
|
C036871 |
|
|
Bodily Secretions
|
D012634 |
[Endogenous substances produced through the activity of intact cells of glands, tissues, or organs.
] |
|
Galphimia glauca extract
|
C036872 |
|
|
Secretory Component
|
D012635 |
[The extracellular moiety of the POLYMERIC IMMUNOGLOBULIN RECEPTOR found alone or complexed with IGA or IGM, in a variety of external secretions (tears, bile, colostrum.) Secretory component is derived by proteolytic cleavage of the receptor during transcytosis. When immunoglobulins IgA and IgM are bound to the receptor, during their transcytosis secretory component becomes covalently attached to them generating SECRETORY IMMUNOGLOBULIN A or secretory IMMUNOGLOBULIN M.
] |
|
safargam
|
C036873 |
|
|
roehybridine-N-oxide
|
C443730 |
|
